Pseudoatrophy of the Brain with Valproic Acid Monotherapy
- 1 August 1987
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 14 (3) , 294-296
- https://doi.org/10.1017/s0317167100026640
Abstract
A patient is described who, while on valproic acid monotherapy, developed reversible shrinkage of the brain, documented by computerized tomography with associated cognitive deficit. Although pseudoatrophy has been reported with steroid therapy, this is the first implication of an anticonvulsant drug in the etiology of that condition.This publication has 12 references indexed in Scilit:
- Reversible Valproic Acid‐Induced Dementia: A Case ReportEpilepsia, 1986
- Computed tomography in infantile spasms: Effects of hormonal therapyPediatric Neurology, 1986
- Valproate hepatotoxicity: Two new cases, a summary of others, and recommendationsPediatric Neurology, 1985
- Adverse Effects of ValproateEpilepsia, 1984
- Sodium valproate and corticotropin suppression in the child treated for seizuresThe Journal of Pediatrics, 1983
- Cranial Computed Tomography (CCT) Findings in Children Treated with ACTH and Dexamethasone: First ResultsNeuropediatrics, 1979
- REVERSIBLE CEREBRAL ATROPHY IN INFANTILE SPASMS CAUSED BY CORTICOTROPHINThe Lancet, 1979
- Reversible Cerebral Atrophy in Recently Abstinent Chronic Alcoholics Measured by Computed Tomography ScansScience, 1978
- Steroids and Apparent Cerebral Atrophy on Computed Tomography ScansJournal of Computer Assisted Tomography, 1978
- Reversibility of Cerebral Atrophy in Anorexia Nervosa and Cushingʼs SyndromeJournal of Computer Assisted Tomography, 1977